GeneDx Holdings Corp.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-93.1M | $-117.2M | $24.1M | $120.2M |
| FY2021 | $-190.4M | $-199.8M | $9.4M | $219.4M |
| FY2022 | $-319.2M | $-326.3M | $7.2M | $42.0M |
| FY2023 | $-180.1M | $-185.4M | $5.3M | $-326.0K |
| FY2024 | $-28.5M | $-34.0M | $5.5M | $9.1M |
| FY2025 | $33.3M | $14.3M | $19.0M | $32.2M |